ELEVANCE HEALTH DL-,01ELEVANCE HEALTH DL-,01ELEVANCE HEALTH DL-,01

ELEVANCE HEALTH DL-,01

No trades
See on Supercharts

Price target

475.100.000.00%
The 18 analysts offering 1 year price forecasts for A58 have a max estimate of — and a min estimate of —.

Analyst rating

Based on 22 analysts giving stock ratings to A58 in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


A58 EPS for the last quarter is 7.52 EUR despite the estimation of 8.67 EUR. In the next quarter EPS is expected to reach 3.78 EUR. Track more of ELEVANCE HEALTH DL-,01 financials and stay on top of what is up with the company.
In the next quarter ELEVANCE HEALTH DL-,01 revenue is expected to reach ‪42.64 B‬ EUR. Check out ELEVANCE HEALTH DL-,01 revenue and earnings and make informed decisions.
According to analysts, A58 price target is 475.10 EUR with a max estimate of 576.89 EUR and a min estimate of 429.20 EUR. Check if this forecast comes true in a year, meanwhile watch ELEVANCE HEALTH DL-,01 stock price chart and keep track of the current situation with A58 news and stock market news.
We've gathered opinions of 22 analysts rating A58 stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.